Peer-reviewed veterinary case report
Radiation and slow-release cisplatin for treating dog nasal tumors
By Lana, Susan E et al.·Published in Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·2004·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors.
- Species:
- dog
Plain-English summary
A group of dogs with nasal tumors received a combination of radiation therapy and a slow-release chemotherapy drug called cisplatin. The treatment was generally well tolerated, and the average survival time for the dogs was around 570 days. This approach showed promise in managing malignant nasal tumors in dogs, with no significant factors affecting survival rates. Overall, the combination of radiation and cisplatin could be a viable option for treating this type of cancer in dogs.
People also search for: dog nasal tumor treatment · cisplatin for dogs · radiation therapy for dog cancer
Abstract
The purpose of this study was to evaluate the combined use of radiation and a slow-release cisplatin chemotherapy formulation for treatment of malignant nasal tumors in dogs. In this retrospective analysis, 51 dogs were evaluated with respect to treatment toxicity, tumor type, stage of disease, cribriform plate involvement, and overall survival. In general, treatment was well tolerated. Mean and median survival as assessed by the Kaplan-Meier product limit method was 570 and 474 days, respectively. No other factors, including tumor type, stage of disease, or cribriform plate invasion had a significant impact on survival. In conclusion, a combination of slow release cisplatin chemotherapy and radiation for the treatment of canine nasal tumors is well tolerated. Results of this analysis warrant further study to elucidate possible other beneficial radiation potentiating drugs and dosing schedules.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/15605853/